Loading news...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) SVP Christopher Wyatt sold 4,000 shares of the firm's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company,
Cherokee Insurance Co reduced its position in shares of HCA Healthcare, Inc. (NYSE: HCA) by 19.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,100 shares of the company's stock after selling 2,000 shares during the quarter.
HCA Healthcare reported strong financial results and encouraging guidance. The medical facilities operator has important long-term growth opportunities.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Shares of HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) have been given an average rating of "Moderate Buy" by the twenty-five analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and sixteen have issued a buy recommendation
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
HCA Healthcare has been quietly implementing AI-assisted tools to improve its business. This makes the company's investment thesis even stronger than it already was.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that three of its hospitals were named among America's 50 Best Hospitals and 15 of its hospitals were named among America's 100 Best Hospitals by Healthgrades. These are part of the 44 HCA Healthcare hospitals recognized on the Healthgrades America's 250 Best Hospitals list for 2026. Inclusion on these lists recognizes superior performance in providing care for c.
HCA Healthcare Inc. (NYSE: HCA) released mixed fourth-quarter 2025 financial results on Tuesday.
HCA Healthcare Inc. (NYSE: HCA) released mixed fourth-quarter 2025 financial results on Tuesday.
HCA Healthcare (NYSE: HCA) executives pointed to continued demand growth, margin improvement, and disciplined capital allocation as the company closed out 2025, while outlining notable policy-related headwinds embedded in its 2026 outlook. Fourth-quarter performance and volume trends Chief Executive Officer Sam Hazen said the company finished the year with "strong results" that were largely consistent with
Compass Wealth Management LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE: HCA) by 95.7% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 550 shares of the company's stock after selling 12,197 shares during the quarter. Compass Wealth Management LLC's
Shares of HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) gapped up before the market opened on Tuesday following a better than expected earnings announcement. The stock had previously closed at $472.38, but opened at $505.00. HCA Healthcare shares last traded at $517.5850, with a volume of 746,310 shares trading hands. The company reported $8.01
HCA Healthcare, Inc. (NYSE: HCA - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Wednesday following a stronger than expected earnings report. The company traded as high as $527.55 and last traded at $506.2920, with a volume of 3082016 shares. The stock had previously closed at $472.38. The company reported
HCA Healthcare, Inc. (HCA) Q4 2025 Earnings Call Transcript